Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)
- Citation:
- Support Care Cancer vol 26 (2) 643-650
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Grants:
- U10CA035101, U10CA035103, U10CA035113, U10CA035119, U10CA035195, U10CA035267, U10CA035269, U10CA035415, U10CA035431, U10CA035448, U10CA037404, U10CA037417, U10CA052352, U10CA063848, U10CA063849, U10CA180790, UG1CA189863, UG1CA189971.
- Corr. Author:
- Authors:
- Debra L. Barton Jeff A. Sloan Lynne T. Shuster Paula Gill Patricia Griffin Kathleen Flynn Shelby A. Terstriep Fauzia N. Rana Travis Dockter Pamela J. Atherton Michaela Tsai Keren Sturtz Jacqueline M. Lafky Mike Riepl Jacqueline Thielen Charles L. Loprinzi
- Networks:
- CO012, LAPS-MN026, MCRC, MONTANA, PCRC, SANFORD, UPSTATE
- Study
- NCCTG-N10C1
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: